Dr. Goldberg discusses using molecular diagnostics to inform a range of cancer management decisions for patients with invasive cutaneous melanoma, squamous cell carcinoma, and in gastroenterology, patients with Barrett's esophagus.
Informing Disease Management Decisions Through Advanced Molecular Diagnostics
1. Identify diseases with high unmet clinical need.
2. Leverage advanced technologies to develop innovative tests.
3. Tests are designed to provide personalized and clinically actionable information based on a patient's unique biology.
4. Test results inform treatment decisions within national guideline and staging recommendations.
Matthew Goldberg, M.D., F.A.A.D.
Senior Vice President, Medical Director / Castle Biosciences
Assistant Clinical Professor of Dermatology
Icahn School of Medicine at Mount Sinai, New York
Presented at the 2023 Precision Medicine World Conference (PMWC)
Негізгі бет Using Molecular Diagnostics to Inform Cancer Management Decisions / by Matthew Goldberg at PMWC 2023
Пікірлер